To The Moon

For institutional allocators and disciplined wealth managers, periodic price movements around moving averages represent routine market consolidation rather than structural deterioration. Attempting to market-time broad index pullbacks often results in drag and missed compounding. A systematic dollar-cost averaging strategy remains the most effective approach for navigating periods where prices trade between the 50-day and 200-day moving averages. Portfolios built around foundational low-cost index ETFs like $Vanguard S&P 500 ETF(VOO)$ benefit from staying fully invested while using tactical pullbacks toward major support levels ($675 and $650 zones) to execute disciplined rebalancing.

$MCD VERTICAL 260904 PUT 255.0/PUT 260.0$ Set up a bull put spread for income.

$Vanguard S&P 500 ETF(VOO)$ currently trades around $680.96, consolidating after touching its 52-week high of $699.15. The fund is navigating a minor short-term consolidation phase, trading just below its 50-day moving average of $682.80 while remaining comfortably above its long-term 200-day moving average near $648.70. The 14-day Relative Strength Index (RSI) stands at 42.3, positioning momentum in neutral territory without signals of being overbought or oversold. Immediate short-term support has formed around $676.00–$678.00, while primary overhead resistance remains firmly anchored near the $696.00–$699.00 price band. watchlist $Micron Technology(MU)$

ARKK Investment Tracker position change: Decreased position in Figma by 615,799 shares, the number of shares held decreased 93.82% compared to the previous period and now represents 0.016% of the total position.

ARKK Investment Tracker position change: Increased position in SoFi Technologies Inc. by 39,956 shares, the number of shares held increased 1.79% compared to the previous period and now represents 0.69% of the total position.

ARKK Investment Tracker position change: Increased position in Alphabet by 1,540 shares, the number of shares held increased 1.79% compared to the previous period and now represents 0.52% of the total position.

ARKK Investment Tracker position change: Increased position in Pacific Biosciences of California by 229,488 shares, the number of shares held increased 1.79% compared to the previous period and now represents 0.33% of the total position.

ARKK Investment Tracker position change: Increased position in Eli Lilly by 504 shares, the number of shares held increased 1.77% compared to the previous period and now represents 0.64% of the total position.

ARKW Investment Tracker position change: Decreased position in Alphabet by 52 shares, the number of shares held decreased 0.42% compared to the previous period and now represents 0.27% of the total position.

ARKK Investment Tracker position change: Increased position in Snowflake by 2,520 shares, the number of shares held increased 1.79% compared to the previous period and now represents 0.71% of the total position.

ARKK Investment Tracker position change: Increased position in BWX Technologies Inc by 4,564 shares, the number of shares held increased 1.78% compared to the previous period and now represents 0.84% of the total position.

ARKK Investment Tracker position change: Increased position in GeneDx Holdings by 15,680 shares, the number of shares held increased 1.79% compared to the previous period and now represents 0.97% of the total position.

ARKW Investment Tracker position change: Decreased position in Airbnb, Inc. by 271 shares, the number of shares held decreased 0.42% compared to the previous period and now represents 0.62% of the total position.

ARKK Investment Tracker position change: Increased position in Teradyne by 2,604 shares, the number of shares held increased 1.79% compared to the previous period and now represents 0.96% of the total position.

For institutional allocators and disciplined wealth managers, periodic price movements around moving averages represent routine market consolidation rather than structural deterioration. Attempting to market-time broad index pullbacks often results in drag and missed compounding. A systematic dollar-cost averaging strategy remains the most effective approach for navigating periods where prices trade between the 50-day and 200-day moving averages. Portfolios built around foundational low-cost index ETFs like $Vanguard S&P 500 ETF(VOO)$ benefit from staying fully invested while using tactical pullbacks toward major support levels ($675 and $650 zones) to execute disciplined rebalancing.

$Vanguard S&P 500 ETF(VOO)$ currently trades around $680.96, consolidating after touching its 52-week high of $699.15. The fund is navigating a minor short-term consolidation phase, trading just below its 50-day moving average of $682.80 while remaining comfortably above its long-term 200-day moving average near $648.70. The 14-day Relative Strength Index (RSI) stands at 42.3, positioning momentum in neutral territory without signals of being overbought or oversold. Immediate short-term support has formed around $676.00–$678.00, while primary overhead resistance remains firmly anchored near the $696.00–$699.00 price band. watchlist $Micron Technology(MU)$

ARKK Investment Tracker position change: Increased position in Pacific Biosciences of California by 229,488 shares, the number of shares held increased 1.79% compared to the previous period and now represents 0.33% of the total position.

ARKK Investment Tracker position change: Increased position in Taiwan Semiconductor Manufacturing by 2,380 shares, the number of shares held increased 1.78% compared to the previous period and now represents 1.01% of the total position.

ARKK Investment Tracker position change: Increased position in Kratos Defense & Security Solutions by 22,624 shares, the number of shares held increased 1.79% compared to the previous period and now represents 1.12% of the total position.

ARKG Investment Tracker position change: Increased position in Pacific Biosciences of California by 237,096 shares, the number of shares held increased 2.22% compared to the previous period and now represents 0.96% of the total position.

ARKG Investment Tracker position change: Increased position in Recursion Pharmaceuticals, Inc. by 304,200 shares, the number of shares held increased 2.22% compared to the previous period and now represents 2.69% of the total position.

ARKK Investment Tracker position change: Increased position in SoFi Technologies Inc. by 39,956 shares, the number of shares held increased 1.79% compared to the previous period and now represents 0.69% of the total position.

ARKK Investment Tracker position change: Decreased position in Figma by 615,799 shares, the number of shares held decreased 93.82% compared to the previous period and now represents 0.016% of the total position.

ARKK Investment Tracker position change: Increased position in Recursion Pharmaceuticals, Inc. by 362,852 shares, the number of shares held increased 1.79% compared to the previous period and now represents 1.12% of the total position.

ARKW Investment Tracker position change: Decreased position in Taiwan Semiconductor Manufacturing by 370 shares, the number of shares held decreased 0.42% compared to the previous period and now represents 2.43% of the total position.

ARKK Investment Tracker position change: Increased position in Alphabet by 1,540 shares, the number of shares held increased 1.79% compared to the previous period and now represents 0.52% of the total position.

ARKG Investment Tracker position change: Increased position in Adaptive Biotechnologies Corp by 39,582 shares, the number of shares held increased 2.22% compared to the previous period and now represents 2.63% of the total position.

ARKW Investment Tracker position change: Decreased position in Palantir Technologies Inc. by 1,543 shares, the number of shares held decreased 0.42% compared to the previous period and now represents 3.08% of the total position.

ARKK Investment Tracker position change: Increased position in Eli Lilly by 504 shares, the number of shares held increased 1.77% compared to the previous period and now represents 0.64% of the total position.

ARKW Investment Tracker position change: Decreased position in CrowdStrike Holdings, Inc. by 1,048 shares, the number of shares held decreased 0.42% compared to the previous period and now represents 3.12% of the total position.

ARKK Investment Tracker position change: Increased position in Palantir Technologies Inc. by 25,200 shares, the number of shares held increased 1.79% compared to the previous period and now represents 3.25% of the total position.

ARKK Investment Tracker position change: Increased position in CRISPR Therapeutics AG by 100,884 shares, the number of shares held increased 1.79% compared to the previous period and now represents 4.92% of the total position.

ARKK Investment Tracker position change: Increased position in Beam Therapeutics, Inc. by 108,892 shares, the number of shares held increased 1.79% compared to the previous period and now represents 2.86% of the total position.

ARKK Investment Tracker position change: Decreased position in Intellia Therapeutics by 121,500 shares, the number of shares held decreased 1.15% compared to the previous period and now represents 2.06% of the total position.